Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CARBOPLATIN INJECTION LIQ 10MG/ML 10 MG

CARBOPLATIN : 10 MG · DIN 01990438 · DAVID BULL LABORATORIES (PTY) LTD.

Health Canada status: CANCELLED POST MARKET

What is CARBOPLATIN INJECTION LIQ 10MG/ML?

CARBOPLATIN INJECTION LIQ 10MG/ML 10 MG contains CARBOPLATIN : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 01990438, held by DAVID BULL LABORATORIES (PTY) LTD., supplied as LIQUID for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 13-Aug-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN01990438
Brand nameCARBOPLATIN INJECTION LIQ 10MG/ML
Generic / active ingredientCARBOPLATIN : 10 MG
ManufacturerDAVID BULL LABORATORIES (PTY) LTD.
Strength10 MG
Dosage formLIQUID
Route of administrationINTRAVENOUS
SchedulePrescription
ATC codeL01XA02 CARBOPLATIN
AHFS class88:08.00 ; 88:12.00
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date13-Aug-1998
Original market date1995-12-31 00:00:00

Is CARBOPLATIN in shortage in Canada?

A Canadian shortage report is on file for this molecule: Resolved — reported by ACCORD HEALTHCARE INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for CARBOPLATIN INJECTION LIQ 10MG/ML

What can be used instead?

Other Canadian products sharing ATC code L01XA02 CARBOPLATIN. 3 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
CARBOPLATIN INJECTION10 MGLIQUIDTEVA CANADA LIMITEDMARKETEDDIN 02125439
CARBOPLATIN INJECTION BP10 MGSOLUTIONPFIZER CANADA ULCMARKETEDDIN 02126680
CARBOPLATIN INJECTION BP10 MGSOLUTIONACCORD HEALTHCARE INCMARKETEDDIN 02320371
CARBOPLATIN INJECTION10 MGSOLUTIONEUGIA PHARMA INC.APPROVEDDIN 02535289
CARBOPLATIN INJECTION10 MGSOLUTIONOMEGA LABORATORIES LIMITEDDORMANTDIN 02366053
CARBOPLATIN INJECTION10 MGSOLUTIONAURO PHARMA INCAPPROVEDDIN 02528916
CARBOPLATIN INJECTION, BP10 MGSOLUTIONSTRIDES PHARMA CANADA INCAPPROVEDDIN 02420228
PARAPLATIN INJ 150MG/VIAL150 MGPOWDER FOR SOLUTIONBRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBBCANCELLED POST MARKETDIN 00680060
PARAPLATIN-AQ INJ 10MG/ML10 MGLIQUIDBRISTOL-MYERS SQUIBB CANADACANCELLED POST MARKETDIN 00788759

Who else supplies CARBOPLATIN worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. CARBOPLATIN appears in 38 registered pack listings across 5 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for CARBOPLATIN INJECTION LIQ 10MG/ML

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for CARBOPLATIN INJECTION LIQ 10MG/ML

Health Canada Drug Product Database (DPD), DIN 01990438. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.